Man Group’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-40,166
Closed -$327K 2528
2026
Q1
$327K Sell
40,166
-2,955
-7% -$26.8K ﹤0.01% 2193
2025
Q4
$290K Buy
+43,121
New +$325K ﹤0.01% 2026
2025
Q3
Sell
-12,850
Closed -$81K 2390
2025
Q2
$81K Buy
+12,850
New +$85.1K ﹤0.01% 2126
2024
Q1
Sell
-25,999
Closed -$125K 2229
2023
Q4
$125K Buy
+25,999
New +$159K ﹤0.01% 1964
2023
Q3
Sell
-35,600
Closed -$284K 1567
2023
Q2
$265K Buy
+35,600
New +$280K ﹤0.01% 1752
2023
Q1
Hold
0
1714
2022
Q4
Sell
-214,722
Closed -$3.91M 2140
2022
Q3
$3.91M Buy
+214,722
New +$9.3M 0.02% 824
2022
Q2
Sell
-5,245
Closed -$272K 812
2022
Q1
$387K Sell
5,245
-50,298
-91% -$4.49M ﹤0.01% 1675
2021
Q4
$7.95M Buy
55,543
+12,469
+29% +$2.14M 0.03% 687
2021
Q3
$8.93M Buy
+43,074
New +$9.49M 0.03% 615
2021
Q2
Sell
-2,994
Closed -$544K 2052
2021
Q1
$544K Sell
2,994
-11,203
-79% -$2.23M ﹤0.01% 1456
2020
Q4
$1.58M Buy
14,197
+5,374
+61% +$571K 0.01% 1271
2020
Q3
$955K Sell
8,823
-120,361
-93% -$14.7M ﹤0.01% 1388
2020
Q2
$10.8M Buy
+129,184
New +$4.94M 0.05% 338

Other funds holding NVAX

Man Group's NVAX Position: Q2 2026 in Review

Man Group sold out of Novavax (NVAX) in Q2 2026, closing a stake of 40,166 shares — an estimated $327K sold.

Man Group first reported a position in NVAX in Q2 2020 and held it in 13 quarters. The position peaked at $10.8M in Q2 2020. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Man Group reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
  • Man Group sold 40,166 Novavax shares in Q2 2026, an estimated $327K.
  • Man Group first reported a position in Novavax in Q2 2020 and held it in 13 quarters.
  • Man Group's Novavax position peaked at $10.8M in Q2 2020.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.